Study details
Enrolling now
Vibrotactile Coordinated Reset Trial
Synergic Medical Technologies, Inc.
NCT IDNCT05881460ClinicalTrials.gov data as of Apr 2026
Target enrollment
30
Study length
about 2.6 years
Ages
45–85
Locations
1 site in OR
About this study
This trial is testing a device called the Vibrotactile (VT) Touch device to help people with Parkinson's disease. The treatment, vibrotactile coordinated reset, may delay the need for more medication and offer flexibility compared to deep brain stimulation.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use Active vibrotactile coordinated reset
- 2.Use Sham vibrotactile coordinated reset
Primary goalChange in Movement Disorders Society's Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part 3
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low11%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Change in Movement Disorders Society's Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part 3
Secondary: Quality of life improvements
Body systems
Neurology